miR-155 influences cell-mediated immunity in Balb/c mice treated with aflatoxin M1. 2021

Kobra Shirani, and Bamdad Riahi Zanjani, and Soghra Mehri, and Kamal Razavi-Azarkhiavi, and Ali Badiee, and A Wallace Hayes, and John P Giesy, and Gholamreza Karimi
Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.

Aflatoxin M1 (AFM1) is a 4-hydroxylated metabolite of aflatoxin B1 (AFB1). It induces various toxicological effects including immunotoxicity. In the present study, we investigated the effects of AFM1 on immune system and its modulation by MicroRNA (miR)-155. AFM1 was administered intraperitoneally at doses of 25 and 50 µg/kg for 28 days to Balb/c mice and different immune system parameters were analyzed. The levels of miR-155 and targeted proteins were evaluated in isolated T cells from spleens of mice. Spleen weight was reduced in mice exposed to AFM1 compared to negative control. Proliferation of splenocytes in response to phytohemagglutinin-A was reduced in mice exposed to AFM1. IFN-γ was decreased in mice exposed to AFM1, whereas IL-10 was increased. Concentration of IL-4 did not change different in mice exposed to AFM1 compared to negative control. Exposure to AFM1 reduced the expression of miR-155. Significant upregulation of phosphatidylinositol-3, 4, 5-trisphosphate 5-phosphatase 1 (Ship1) and suppressor of cytokine signaling 1 (Socs1) was observed in isolated T cells from spleens of mice treated with AFM1, but the transcription factor Maf (c-MAF) was not affected. These results suggest that miR-155 and targeted proteins might be involved in the immunotoxicity observed in mice exposed to AFM1.

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007274 Injections, Intraperitoneal Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall. Intraperitoneal Injections,Injection, Intraperitoneal,Intraperitoneal Injection
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008297 Male Males
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D000071222 Suppressor of Cytokine Signaling 1 Protein A suppressor of cytokine signaling protein that consists of an N-terminal kinase-inhibitory region, a central SH2 DOMAIN, a characteristic C-terminal SOCS box (a 40-amino acid motif, which functions to recruit E3 UBIQUITIN-PROTEIN LIGASE COMPLEXES). SOCS1 functions as a negative regulator of CYTOKINES that signal through the JANUS KINASES-STAT 3 TRANSCRIPTION FACTOR (JAK/STAT3) pathway by inhibiting the activity of JANUS KINASES. SOCS1 Protein,Suppressor of Cytokine Signaling Protein 1 -,Protein, SOCS1,Suppressor of Cytokine Signaling Protein 1
D000072183 Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases Phosphoinositide phosphatases that catalyze the dephosphorylation (hydrolysis) of phosphatidylinositol-3,4,5-trisphosphate (PtdIns(3,4,5)P(3)) to produce PtdIns(3,4)P(2), which negatively regulates the PI3K ( 3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASES) pathways. They contain an SH2 DOMAIN and STERILE ALPHA MOTIF and have important functions in regulating the immune response and other cellular processes in vertebrates. SHIP Phosphatases,Src Homology 2 Domain-Containing Inositol Phosphatases,Phosphatases, SHIP,Src Homology 2 Domain Containing Inositol Phosphatases
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013154 Spleen An encapsulated lymphatic organ through which venous blood filters.

Related Publications

Kobra Shirani, and Bamdad Riahi Zanjani, and Soghra Mehri, and Kamal Razavi-Azarkhiavi, and Ali Badiee, and A Wallace Hayes, and John P Giesy, and Gholamreza Karimi
November 1975, Journal of immunology (Baltimore, Md. : 1950),
Kobra Shirani, and Bamdad Riahi Zanjani, and Soghra Mehri, and Kamal Razavi-Azarkhiavi, and Ali Badiee, and A Wallace Hayes, and John P Giesy, and Gholamreza Karimi
November 1989, Journal of immunology (Baltimore, Md. : 1950),
Kobra Shirani, and Bamdad Riahi Zanjani, and Soghra Mehri, and Kamal Razavi-Azarkhiavi, and Ali Badiee, and A Wallace Hayes, and John P Giesy, and Gholamreza Karimi
April 2023, Cellular immunology,
Kobra Shirani, and Bamdad Riahi Zanjani, and Soghra Mehri, and Kamal Razavi-Azarkhiavi, and Ali Badiee, and A Wallace Hayes, and John P Giesy, and Gholamreza Karimi
March 2011, Immunopharmacology and immunotoxicology,
Kobra Shirani, and Bamdad Riahi Zanjani, and Soghra Mehri, and Kamal Razavi-Azarkhiavi, and Ali Badiee, and A Wallace Hayes, and John P Giesy, and Gholamreza Karimi
March 1972, Transplantation,
Kobra Shirani, and Bamdad Riahi Zanjani, and Soghra Mehri, and Kamal Razavi-Azarkhiavi, and Ali Badiee, and A Wallace Hayes, and John P Giesy, and Gholamreza Karimi
December 2016, Journal of molecular cell biology,
Kobra Shirani, and Bamdad Riahi Zanjani, and Soghra Mehri, and Kamal Razavi-Azarkhiavi, and Ali Badiee, and A Wallace Hayes, and John P Giesy, and Gholamreza Karimi
July 2003, Journal of immunology (Baltimore, Md. : 1950),
Kobra Shirani, and Bamdad Riahi Zanjani, and Soghra Mehri, and Kamal Razavi-Azarkhiavi, and Ali Badiee, and A Wallace Hayes, and John P Giesy, and Gholamreza Karimi
July 2014, Bing du xue bao = Chinese journal of virology,
Kobra Shirani, and Bamdad Riahi Zanjani, and Soghra Mehri, and Kamal Razavi-Azarkhiavi, and Ali Badiee, and A Wallace Hayes, and John P Giesy, and Gholamreza Karimi
April 1988, Infection and immunity,
Kobra Shirani, and Bamdad Riahi Zanjani, and Soghra Mehri, and Kamal Razavi-Azarkhiavi, and Ali Badiee, and A Wallace Hayes, and John P Giesy, and Gholamreza Karimi
June 1999, Immunology,
Copied contents to your clipboard!